Skip to Content

Join the 'Mesalamine' group to help and get support from people like you.

Mesalamine News

Special Diet May Be Boon for Kids With Crohn's, Colitis

Posted 10 Jan 2017 by Drugs.com

MONDAY, Jan. 9, 2017 – Children with Crohn's disease and ulcerative colitis may be able to achieve relief without medications by eating a special diet, a small study suggests. The diet includes non-processed foods, such as fruits, vegetables, meats and nuts. Over 12 weeks, the diet appeared to ease all signs of these inflammatory bowel diseases in eight of the 10 affected children, researchers ...

Study Identifies Genetic Subtypes of Crohn's Disease

Posted 14 Oct 2016 by Drugs.com

FRIDAY, Oct. 14, 2016 – Crohn's disease appears to have at least two distinct genetic subtypes, which could explain why the condition is so hard to treat, a new study suggests. "The one-treatment-fits-all approach doesn't seem to be working for Crohn's patients," said study co-senior author Dr. Shehzad Sheikh. He's an assistant professor in the departments of medicine and genetics at the ...

Stem Cell Transplants May Not Help Tough-to-Treat Crohn's, Study Says

Posted 15 Dec 2015 by Drugs.com

TUESDAY, Dec. 15, 2015 – Stem cell transplants seem no better than conventional therapy for Crohn's disease that hasn't responded to other treatments, a new study finds. The European study also found that for patients who cannot undergo surgery for the condition, stem cell transplants resulted in serious side effects, including infections. "In this group of the most resistant cases of Crohn's ...

Crohn's Disease Treatments for Kids May Not Get Gut Back to Normal

Posted 14 Oct 2015 by Drugs.com

WEDNESDAY, Oct. 14, 2015 – Current therapies for children with Crohn's disease don't fully restore healthy bacteria and fungi populations in their digestive systems, a new study shows. These findings suggest that treatments don't have to bring bacteria and other microbe levels back to normal levels in the gut to be useful. This knowledge could lead to new approaches for diagnosing and treating ...

Warner Chilcott Announces FDA Approval of New Ulcerative Colitis Product Delzicol

Posted 6 Feb 2013 by Drugs.com

DUBLIN, Ireland, Feb. 5, 2013 – Warner Chilcott plc today announced that the United States Food and Drug Administration (FDA) has approved its new 400 mg mesalamine product indicated for the treatment of ulcerative colitis. The product will be marketed as Delzicol (mesalamine) 400 mg delayed-release capsules. The Company anticipates that it will commercially launch Delzicol in March 2013. About ...

Lialda (Mesalamine) Now Approved in U.S. for Maintenance of Remission of Ulcerative Colitis

Posted 18 Jul 2011 by Drugs.com

Lialda has been indicated for the induction of remission in patients with active, mild to moderate ulcerative colitis and is now also approved for the maintenance of remission of ulcerative colitis PHILADELPHIA, July 18, 2011 /PRNewswire/ – Shire plc (LSE: SHP; NASDAQ: SHPGY), the global specialty biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) ...

Ask a Question

Further Information

Related Condition Support Groups

Ulcerative Colitis - Maintenance, Crohn's Disease - Maintenance, Ulcerative Colitis - Active, Inflammatory Bowel Disease, Ulcerative Colitis, Ulcerative Proctitis, Crohn's Disease, Lymphocytic Colitis

Related Drug Support Groups

Asacol, Pentasa, Lialda, Apriso, Canasa, Delzicol, Asacol HD, Rowasa, Canasa Pac, FIV-ASA, Mesasal Enteric Coated, Salofalk

Mesalamine Patient Information at Drugs.com